Maximilian Winter is General Partner at Harmonix Fund. He is a fourth-generation entrepreneur and founder of two funds invested in 40+ early-stage companies with an enterprise valuation of $5B. Maximilian invests in scalable technological breakthroughs to advance human health and scientific progress. His focus is improving healthcare, accelerating life sciences, and creating deep tech infrastructure, the building blocks for a healthy, operational, and peaceful civilization.
His philanthropic foundation, The Winter Family Foundation, established with his brother, Alexander Winter, is another avenue for his societal contributions. He is passionate about well-being, meditation, traveling, reading.
Krish Ramadurai is a Partner at Harmonix Fund, leading the firm’s technical due diligence, investment sourcing, and portfolio operational support across their healthcare, life sciences, and deep technology practices. He is a multi-published author, advisor, lecturer, and former researcher at Harvard & MIT. While at Harvard, he worked with Nobel Laureate Economist Michael Kremer on the United States Agency for International Development’s Innovation Ventures Fund and authored three books on medicine and applied engineering. He serves as a venture advisor for Nucleate and is a board observer for Sorcero and xCures. He has been nominated for multiple industry awards including Forbes 30 Under 30 in venture capital and the NVCA Rising Star Award. He has advanced degrees in Biology, Nanotechnology & Nanomedicine, and Business Administration from Harvard University, Oxford University, and Washington University in St. Louis, respectively, and a bachelor’s degree in Integrative Biology and Economics with a Chemistry minor from the University of Illinois at Urbana-Champaign. In his spare time, he enjoys traveling and is an avid classic car enthusiast.
Cofield is Chief Operating Officer and partner at Harmonix, where she provides strategic support for the fund and its 40+ companies.. She is a founder and business leader with 30+ years of experience in operational roles.
Cofield grew up in South Africa, and has lived in Botswana, Kenya, London and the United States. She managed and led teams of up to 45+ in various verticals, including interior lifestyle brands, import and export and the entertainment industry.
Cofield is also an accomplished recording artist who was signed to Sony and Universal Music and is an Ambassador for the 46664 Nelson Mandela Foundation.
During her career in the entertainment industry, Cofield nurtured, managed and developed talent for the global stage.
Her unique specialty is coaching, negotiating and evaluating character for assembling successful teams, which she artfully brings to her role in Venture Capital.
Managing Director of Marketing and Investor Relations
Anthony DeFeo is currently the Managing Director of Marketing and Investor Relations at Harmonix, with more than 15 years of experience in the industry. He has an impressive track record of raising over $1B in capital throughout his career. Before joining Harmonix, he held a similar position at CKC Capital, a hedge fund focusing on corporate credit. Prior to that, he was responsible for marketing at two healthcare-focused hedge funds, Orchard View Capital and Sio Capital. He also gained experience as a Marketing Associate at Exis Capital and as Assistant Vice President Relationship Manager at JPMorgan Chase & Co.
Anthony holds an MBA from Fordham University, where he was the class President and an undergraduate degree in Italian language from New York University. His educational background and wealth of experience make him well-equipped to excel in his role at Harmonix, where he promotes the brand and attracts investors to support the company’s growth.
Partnership and Network Lead
Katya has mentored and invested in over 150 startups, raised 4 funds, and achieved multiple exits for her ventures and portfolio companies, with her investments and exit values exceeding 400M. She has been featured globally in Entrepreneur, Business Insider, and other publications.
With over 10 years of professional experience on Wall Street and in the startup ecosystem, she invests in companies that reduce inequalities, focusing on health and wellness, affordable energy and environment, responsible consumption, and sustainable production.
She is an advocate for immigrant entrepreneurship and a founder for the Immigrant Entrepreneurship Foundation.
Katya writes books for children, donating the royalties to charity.
Paul has over 20 years of experience as a scientist and entrepreneur developing and commercializing tools in genomics and DNA sequencing.
Anna has 20+ years of senior global leadership roles at Roche and Illumina.
Dr. David Messina is the COO of Cofactor Genomics and has spent the last 20+ years in computational biology and genetics.
Founder and CEO of 3 diagnostic companies
PhD in Neurobiology (Alzheimer’s research), MS in Biochemistry( Cancer research)
Research with Nobel Laureate Roger Kornberg at Stanford University
VC experience in Health Tech and Biotech
Director of External Innovation at Dewpoint Therapeutics.
Previous Director of Healthcare & Life Sciences at Harvard Innovation Labs.
Co-led planning of Life Lab Longwood at Harvard Medical School.
Former Assistant Professor of Biomedical Engineering and Director of the Center for Medical Materials & Biophotonics at Florida Institute of Technology.
Ph.D. in Biomedical Engineering, M.S. in Materials Science and Engineering, and B.S. in Chemistry/Biochemistry, all from the University of Florida.
Served as cofounder & advisor for multiple startups.